Kaufman Jonathan H — SEC Form 4 filings
SEC reporting owner CIK 1959250. 9 Form 4 filings on record with FilingPulse; latest filed 2025-04-07.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-03-15 to 2025-04-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings — 65,000 shares, $53,042 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: purchase of 30,000 shares @ $0.79 ($23,649) in LIPELLA PHARMACEUTICALS INC., filed 2024-03-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LIPELLA PHARMACEUTICALS INC. (LIPO) | See remarks below., Director, 10% owner | 9 | 3 legs · 65,000 sh · $53,042 | — | 17 |
Form 4 filings — Kaufman Jonathan H
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-04-07 | 4 | LIPELLA PHARMACEUTICALS INC. (LIPO) | Other (J): 536,959 (derivative) @ $0 · Other (J): 125,833 (derivative) @ $0 · Other (J): 28,924 (derivative) @ $0 · Other (J): 4,060 (derivative) @ $0 | EDGAR |
| 2025-03-17 | 4 | LIPELLA PHARMACEUTICALS INC. (LIPO) | Other (J): 10,326 (derivative) @ $0 · Other (J): 4,060 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | LIPELLA PHARMACEUTICALS INC. (LIPO) | Other (J): 84,700 (derivative) @ $0 · Other (J): 28,924 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | LIPELLA PHARMACEUTICALS INC. (LIPO) | Other (J): 441,933 (derivative) @ $0 · Other (J): 125,833 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | LIPELLA PHARMACEUTICALS INC. (LIPO) | Other (J): 303,041 (derivative) @ $0 · Other (J): 85,421 (derivative) @ $0 · Other (J): 11,795 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | LIPELLA PHARMACEUTICALS INC. (LIPO) | Other (J): 42,933 (derivative) @ $0 · Other (J): 11,795 (derivative) @ $0 | EDGAR |
| 2024-05-15 | 4 | LIPELLA PHARMACEUTICALS INC. (LIPO) | Purchase (P): 10,000 @ $0.76 | EDGAR |
| 2024-03-19 | 4 | LIPELLA PHARMACEUTICALS INC. (LIPO) | Purchase (P): 30,000 @ $0.79 · Purchase (P): 25,000 @ $0.87 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2024-03-15 | 4 | LIPELLA PHARMACEUTICALS INC. (LIPO) | Grant/award (A): 144,906 @ $0.69 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1959250 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →